

The Challenge: Detecting Recurrent Disease
PET/CT Helps Identify Patients Who Are Surgical Candidates
“(FDG-PET) alters patient management in that it enables appropriate selection of patients for different treatments based on accurate results regarding the presence and extent of recurrence.” Arulampalam T, et al 3
PET/CT Effectively Identifies Post-operative Recurrence of Colorectal Cancer
Diagnostic Accuracy of PET/CT in Colorectal Cancer
| SENSITIVITY | SPECIFICITY | NPV | PPV | |
| DX/STAGING | ||||
| PET | 85%2 | 71%2 | 99%2 | 95%2 |
| CT | 34%2 | 92%2 | 86%2 | 50%2 |
| RECURRENCE | ||||
| PET | 94%2 | 87%2 | 88%2 | 93%2 |
| CT | 79%2 | 73%2 |
PET/CT Influenced Patient Management
![]() |
References
1. Steele G, et al. A prospective evaluation of hepatic resection for colorectal
carcinoma metastases to the liver: Gastrointestinal Tumor Story Group protocol
6584. J Clin Oncol. 1991;9:1105-1112.
2. Gambhir SS, Czernin J, Schwimmer J, Silverman DHS, Coleman RE, Phelps ME.
A tabulated summary of the FDG PET literature. J Nucl Med.2001;42(suppl):1S-93S.
3. Arulampalam T, Costa D, Visvikis D, Boulos P, Taylor I, Lee P. The impact
of FDG-PET on the management algorithm for recurrent colorectal cancer. Eur
J Nucl Med. 2001;28:1758-1765.
Medicare Recognizes the Utility of PET/CT in Colorectal Cancer*
Diagnosis
Staging
Restaging
* New medical evidence supports the use of PET as a useful tool in determining the presence of hepatic/extrahepatic Metastases in the primary staging of colorectal carcinoma, prior to selecting a treatment regimen. Use of PET is also supported in evaluating recurrent colorectal cancer beyond the limited presentation of a rising CEA level where the patient presents with clinical signs or symptoms of recurrence.
** For most solid tumors a tissue diagnosis is usually performed prior to a PET/CT scan.
PET/CT Reveals Extent of Metastases in Patient with Colorectal Cancer

History
A patient with history of colon cancer and post-chemotherapy treatment presents
with rising tumor markers (CEA).
CT Findings
CT findings are negative.
PET Findings
PET/CT scan for recurrence shows two active sites of tumor recurrence in the
pelvis.
Change in Treatment
Management reevaluated.